Core A: Administrative Core
核心A:行政核心
基本信息
- 批准号:10203851
- 负责人:
- 金额:$ 15.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-26 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:AchievementAdvocacyAdvocateBasic ScienceCancer BiologyClinicalClinical ResearchCollaborationsCommunicationConflict (Psychology)ConsultationsDataDevelopmentDisputesEnsureEvaluationFoundationsFundingFutureGoalsGovernmentGrantHuman ResourcesHuman Subject ResearchInfrastructureInstitutionLaboratory FindingLeadershipMalignant neoplasm of lungMonitorNational Cancer InstituteOccupational activity of managing financesPatientsPhilanthropic FundPreparationPrincipal InvestigatorPrivatizationProgram EvaluationProgress ReportsPublicationsRegulationResearchResearch PersonnelResearch PriorityResourcesSeriesSourceTimeTimeLineTranslational ResearchTranslationsUnited States National Institutes of HealthUniversitiesYale Cancer Centeranticancer researchcareercost effectivemeetingsneoplasm resourcenoveloperationoutreachpersonalized medicineprogramssuccesssymposiumtranslational cancer researchwebsite development
项目摘要
CORE SUMMARY
The Administrative Core (Core A) is directed by Roy Herbst, Principal Investigator of the Yale SPORE in Lung
Cancer (YSILC), and co-directed by Ed Kaftan, with support from the program financial management team.
Careful oversight by the Administrative Core will be critical to ensure the success of the Yale SPORE in Lung
Cancer. Core A is an extension of existing infrastructure provided by YCC Research Administration to support
and facilitate transdisciplinary research efforts. The Administrative Core serves as the central coordination
point for all YSILC investigators, with responsibility for monitoring the progress of all projects and cores toward
a translational/clinical endpoint. The Core Director and Co-Director along with the YISLC Co-PI (Dr. Chen)
have responsibility for leading the YSILC program, setting translational research priorities, identifying new
translational research opportunities from emerging data, monitoring the progress of all projects, cores and
developmental projects and determining changes in direction of projects, cores and translational research as
needed. Interactions among YSILC investigators is facilitated by Core A to accelerate the translation of
laboratory findings into the proposed and future clinical studies. If required, the Core A Director will manage
conflicts among YSILC investigators. As a team, the Core personnel monitors finances, maintains
communications among project and core leaders and coordinates meetings, including the weekly lung cancer
translational group seminar series, monthly meetings of the Executive Committee, annual meetings of the
Internal/External Advisory boards and the annual YSILC SEP and DRP Symposium. In addition to these
functions, the Core is the primary interface with the NCI, other lung cancer SPOREs, Yale Cancer Center and
Yale University, and coordinates outreach efforts, including publications (internal and external), website
development, seminars, patient/research advocacy activities, and fundraising programs. Through these
administrative activities, Core A is essential to the organization of the YSILC program, to developing a
widespread culture of lung cancer basic/clinical/translational research at Yale and to the efficient achievement
of the stated program objectives, with the ultimate goal of a significant clinical impact for patients with lung
cancer.
核心摘要
行政核心(核心 A)由耶鲁大学 SPORE 肺科首席研究员 Roy Herbst 指导
癌症 (YSILC),由 Ed Kaftan 联合指导,并得到项目财务管理团队的支持。
行政核心的认真监督对于确保耶鲁 SPORE 在肺部的成功至关重要
癌症。 Core A 是 YCC 研究管理部门提供的现有基础设施的扩展,用于支持
并促进跨学科研究工作。行政核心作为中央协调
所有 YSILC 调查员的重点,负责监控所有项目和核心的进展,以实现
转化/临床终点。核心董事和联合董事以及YISLC Co-PI(陈博士)
负责领导 YSILC 项目、设定转化研究优先事项、确定新的
来自新兴数据的转化研究机会,监测所有项目、核心和
开发项目并确定项目、核心和转化研究方向的变化
需要。核心 A 促进了 YSILC 研究人员之间的互动,以加速研究的转化
实验室研究结果纳入拟议的和未来的临床研究。如果需要,核心 A 总监将负责管理
YSILC 调查员之间的冲突。作为一个团队,核心人员监控财务、维护
项目和核心领导人之间的沟通和协调会议,包括每周的肺癌会议
翻译小组研讨会系列、执行委员会月度会议、翻译小组年会
内部/外部顾问委员会以及年度 YSILC SEP 和 DRP 研讨会。除了这些
功能,核心是与 NCI、其他肺癌 SPORE、耶鲁癌症中心和
耶鲁大学,并协调外展工作,包括出版物(内部和外部)、网站
开发、研讨会、患者/研究宣传活动和筹款计划。通过这些
管理活动,核心 A 对于 YSILC 计划的组织、开发
耶鲁大学肺癌基础/临床/转化研究的广泛文化和高效成果
既定的计划目标,最终目标是对肺病患者产生重大临床影响
癌症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roy S Herbst其他文献
Precision needle-punch tumor enrichment from paraffin blocks improves the detection of clinically actionable genomic alterations and biomarkers
从石蜡块中进行精密针刺肿瘤富集可改善临床上可操作的基因组改变和生物标志物的检测
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:4.7
- 作者:
D. Lin;R. Huang;Ioannis Ladas;R. B. Keller;Nimesh R. Patel;S. Lakis;B. Decker;Tyler Janovitz;Douglas A Mata;Jeffrey S. Ross;J. Vergilio;J. Elvin;Roy S Herbst;Philip C. Mack;J. K. Killian - 通讯作者:
J. K. Killian
A process to reanalyze clinical DNA sequencing data for biomarker matching in the Lung-MAP Master Protocol
在 Lung-MAP Master Protocol 中重新分析临床 DNA 测序数据以进行生物标志物匹配的过程
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
J.W. Neal;K. Minichiello;Ryan Brennick;Richard S P Huang;Matthew C. Hiemenz;Cornel Amler;Jyoti D. Patel;Roy S Herbst;K. Reckamp;Hossein Borghaei;Louise Highleyman;M. Redman;L. Pasquina;D. Kozono - 通讯作者:
D. Kozono
Angiogenesis inhibitors in clinical development for lung cancer.
肺癌临床开发中的血管生成抑制剂。
- DOI:
10.1053/sonc.2002.31527 - 发表时间:
2002-02-01 - 期刊:
- 影响因子:4
- 作者:
Roy S Herbst;M. Hidalgo;A. Scott Pierson;Scott N Holden;M. Bergen;S. Eckhardt - 通讯作者:
S. Eckhardt
Electronic Nicotine Delivery Systems: An Updated Policy Statement From the American Association for Cancer Research and the American Society of Clinical Oncology.
电子尼古丁输送系统:美国癌症研究协会和美国临床肿瘤学会的最新政策声明。
- DOI:
10.1200/jco.22.01749 - 发表时间:
2022-10-26 - 期刊:
- 影响因子:0
- 作者:
Roy S Herbst;Dorothy Hatsukami;Dana Acton;M. Giuliani;Allyn Moushey;Jonathan Phillips;Shimere Sherwood;B. Toll;K. Viswanath;Nicholas J H Warren;Graham W Warren;A. Alberg - 通讯作者:
A. Alberg
Novel Approach to Accelerate Lung Cancer Research: Lung-MAP and the Potential of Public-Private Partnerships
加速肺癌研究的新方法:Lung-MAP 和公私合作的潜力
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:11.5
- 作者:
Roy S Herbst;C. Blanke;E. Sigal - 通讯作者:
E. Sigal
Roy S Herbst的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roy S Herbst', 18)}}的其他基金
Yale SPORE in Lung Cancer Developmental Research Program
耶鲁大学 SPORE 肺癌发展研究项目
- 批准号:
10203857 - 财政年份:2015
- 资助金额:
$ 15.48万 - 项目类别:
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
耶鲁 SPORE 肺癌 (YSILC):肺癌的生物学和个性化治疗
- 批准号:
8931829 - 财政年份:2015
- 资助金额:
$ 15.48万 - 项目类别:
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
耶鲁 SPORE 肺癌 (YSILC):肺癌的生物学和个性化治疗
- 批准号:
10203850 - 财政年份:2015
- 资助金额:
$ 15.48万 - 项目类别:
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
耶鲁 SPORE 肺癌 (YSILC):肺癌的生物学和个性化治疗
- 批准号:
9338869 - 财政年份:2015
- 资助金额:
$ 15.48万 - 项目类别:
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
耶鲁 SPORE 肺癌 (YSILC):肺癌的生物学和个性化治疗
- 批准号:
9767058 - 财政年份:2015
- 资助金额:
$ 15.48万 - 项目类别:
MicroRNA-based interventions to prevent progression from lung preneoplasia to adenocarcinoma
基于 MicroRNA 的干预措施可预防肺肿瘤前期发展为腺癌
- 批准号:
9379210 - 财政年份:2015
- 资助金额:
$ 15.48万 - 项目类别:
相似国自然基金
面向社交电商的产品虚假宣传防治关键技术研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
关键金属重大研究计划科普宣传与公共服务
- 批准号:92162320
- 批准年份:2021
- 资助金额:100 万元
- 项目类别:地区科学基金项目
基于社交媒体用户行为的个性化电影宣传片生成方法研究
- 批准号:
- 批准年份:2019
- 资助金额:24 万元
- 项目类别:青年科学基金项目
基于社交媒体用户行为的个性化电影宣传片生成方法研究
- 批准号:61902201
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
敬畏感对于不诚信行为的多维影响和应用研究:基于营销诚信及诚信宣传的视角
- 批准号:71672169
- 批准年份:2016
- 资助金额:48.0 万元
- 项目类别:面上项目
相似海外基金
myAURA: Personalized Web Service for Epilepsy Management
myAURA:用于癫痫管理的个性化 Web 服务
- 批准号:
10414826 - 财政年份:2021
- 资助金额:
$ 15.48万 - 项目类别:
Geriatric Oncology Research Infrastructure to Improve Clinical Care
改善临床护理的老年肿瘤学研究基础设施
- 批准号:
10667860 - 财政年份:2018
- 资助金额:
$ 15.48万 - 项目类别:
Core 3: Communications, Administrations, Advocacy, and Project Management
核心 3:沟通、行政、宣传和项目管理
- 批准号:
10628613 - 财政年份:2017
- 资助金额:
$ 15.48万 - 项目类别: